Langcongan, Aisa .
HRN: 09-47-65 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2023
CEFTAZIDIME 1GM (VIAL)
06/08/2023
06/14/2023
IV
1g
Q8
DM Foot
Waiting Final Action
06/08/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/08/2023
06/14/2023
IV
600mg
Q6
DM Foot
Waiting Final Action
06/08/2023
MUPIROCIN 2%, 15G (TUBE)
06/08/2023
06/14/2023
TOPICAL
2%
TID
DM Foot
Waiting Final Action